Ref.: BL-RE-093449Manufacturer ref.: EH391RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human Relaxin-1 quantitates human Relaxin-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Relaxin-1.
Human Relaxin-1 quantitates human Relaxin-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Relaxin-1.
Human Relaxin-1 quantitates human Relaxin-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Relaxin-1.
Relaxins are known endocrine hormones and autocrine/paracrine hormones, belonging to the superfamily of insulin genes. In humans, there are three genes of non-allenic relaxin, RLN1, RLN2, and RLN3. RLN1 and RLN2 share a high sequence homology. This coded protein is synthesized as a single chain polypeptide, but the active form consists of an A chain and B chain bound by disulfide bonds; however, their exact cleavage sites have not been described. Relaxin is produced by the ovary and targets the reproductive system of mammals to make the cervix mature, lengthen the pubic symphysis and inhibit the contraction of the uterus. It can play an additional role in improving sperm motility, regulating blood pressure, controlling heart rate, and releasing l-oxytocin and vasopressin. This gene has several polyadenylation sites. Several alternative-spinning transcription variants are described for this gene, but their full length nature is not yet known.
Sensitivity
Sensitivity of the dosage: 0.23 ng/ml.
Measurement range
Dose range: 0.23 to 50 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Relaxine 1.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).